Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade

Sequential combination of immunogenic cell death (ICD)-induced interventions with subsequent immunotherapy has shown efficacy in preclinical models and clinical evaluation. Recently, a clinical trial enrolling small cell lung cancer patients treated with amrubicin together with PD-1 blockade confirm...

Full description

Bibliographic Details
Main Authors: Guido Kroemer, Oliver Kepp
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:OncoImmunology
Subjects:
immunotherapy
anthracycline
lung cancer
Online Access:http://dx.doi.org/10.1080/2162402X.2021.1996686

Internet

http://dx.doi.org/10.1080/2162402X.2021.1996686

Similar Items